PRESS RELEASES

EPIVAX THERAPEUTICS APPOINTS NICOLE RUGGIERO AS CHIEF EXECUTIVE OFFICER AND GUILHEM RICHARD AS CHIEF TECHNOLOGY OFFICER

March 29, 2022

EpiVax Therapeutics is excited to announce the appointment of Nicole Ruggiero as Chief Executive Officer and Guilhem Richard as Chief Technology Officer.

Learn More

NEWS

CSE Presents Tech Tuesday - Precision Medicine in Cancer Treatment

October 18, 2022

What if the First Coronavirus Vaccines Aren't the Best?

August 27, 2020

EpiVax Oncology Prepares a Clinical Trial for Precision Medicine/Immunotherapy Cancer Treatment

January 15, 2020

How Your Genes Could be Used to Cure Cancer

August 9, 2018